in vitro diagnostics, clinical laboratories, digital health regulation
Duration: January 1, 2011
to
present
General Issues: Health Issues , Medical/Disease Research/Clinical Labs , Medicare/Medicaid
Spending: about $806,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2011: House of Representatives, U.S. Senate, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA),, U.S. Senate,, Office of Management & Budget (OMB)
Affiliated organizations: Genomic Health Inc.
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Sheila D. Walcoff 2006-2007: Counselor to the Honorable Michael O. Leavitt
(Immediate Office of the Secretary); US. Dept. Of Health and
Human Serivces; 2004-2006: Assoc Commissioner for External
Relations, U.S. FDA; 1998-1999: Majority Counsel, Armed
Service Committee, U.S. House of Reprsentatives
Sheila Walcoff 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed
2006-07: Counselor to HHS Secretary Michael O.
Leavitt (Immediate Office of the Secretary), US
Dept of Health & Human Service 2004-2006
Assoc Commissioner for External Relations, US
FDA; 1998-99 Majority Counsel Armed Services
Committee, US House Of Representatives
Leavitt (Immediate Office of the Secretary), US
Dept. of Health and Human Services; 2004-2006
Hannah Murphy n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
Goldbug Strategies LLC amended a lobbying report for representation of Coalition for 21st Century Medicine in Q42023 on Feb. 13.
Original Filing: 301544145.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Jan. 30.
Original Filing: 301542476.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Type of Issue
Health Issues/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Oct. 24, 2023.
Original Filing: 301517581.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Aug. 9, 2023.
Original Filing: 301494794.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on April 18, 2023.
Original Filing: 301455051.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2022
Goldbug Strategies LLC amended a lobbying report for representation of Coalition for 21st Century Medicine in Q42022 on Jan. 20, 2023.
Original Filing: 301440584.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Jan. 19, 2023.
Original Filing: 301433482.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2022
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Oct. 21, 2022.
Original Filing: 301420577.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2022
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Aug. 2, 2022.
Original Filing: 301398000.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2022
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on April 29, 2022.
Original Filing: 301373797.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Feb. 1, 2022.
Original Filing: 301340472.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Oct. 28, 2021.
Original Filing: 301316449.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $5,500. The report was filed on July 9, 2021.
Original Filing: 301274596.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $7,000. The report was filed on April 22, 2021.
Original Filing: 301268936.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2020
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on Jan. 14, 2021.
Original Filing: 301231254.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on Oct. 9, 2020.
Original Filing: 301208413.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $19,000. The report was filed on July 10, 2020.
Original Filing: 301186672.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $19,500. The report was filed on April 17, 2020.
Original Filing: 301169334.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $20,000. The report was filed on Jan. 13, 2020.
Original Filing: 301104637.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $20,000. The report was filed on Oct. 18, 2019.
Original Filing: 301071121.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2019
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $20,000. The report was filed on July 17, 2019.
Original Filing: 301047969.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2019
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $20,000. The report was filed on April 20, 2019.
Original Filing: 301032680.xml
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
in vitro diagnostics, clinical laboratories, digital health regulation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2018
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $20,000. The report was filed on Jan. 28, 2019.
Original Filing: 301019126.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health. VALID Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software. VALID Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2018
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on Oct. 18, 2018.
Original Filing: 300989298.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2018
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on July 20, 2018.
Original Filing: 300977493.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2018
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on April 20, 2018.
Original Filing: 300958366.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2017
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on Jan. 31, 2018.
Original Filing: 300939386.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2017
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on Oct. 23, 2017.
Original Filing: 300917374.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2017
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine . The report was filed on July 20, 2017.
Original Filing: 300895643.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2017
Goldbug Strategies LLC amended a lobbying report for representation of Coalition for 21st Century Medicine in Q22017 on July 20, 2017.
Original Filing: 300895726.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2017
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on April 20, 2017.
Original Filing: 300878178.xml
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2016
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Jan. 30, 2017.
Original Filing: 300859538.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative,
software for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, software for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2016
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Oct. 20, 2016.
Original Filing: 300834442.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on July 15, 2016.
Original Filing: 300810914.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on April 20, 2016.
Original Filing: 300803647.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Jan. 20, 2016.
Original Filing: 300784460.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $20,000. The report was filed on Oct. 21, 2015.
Original Filing: 300765652.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
Goldbug Strategies LLC amended a lobbying report for representation of Coalition for 21st Century Medicine in Q32015 on Oct. 21, 2015.
Original Filing: 300765654.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on July 30, 2015.
Original Filing: 300748104.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2015
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on April 26, 2015.
Original Filing: 300728817.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2015
Goldbug Strategies LLC amended a lobbying report for representation of Coalition for 21st Century Medicine in Q12015 on April 26, 2015.
Original Filing: 300728819.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies
for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Jan. 19, 2015.
Original Filing: 300700227.xml
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Medicare reimbursement for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Medicare reimbursement for laboratory developed tests and in vitro diagnostic products.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
3rd Quarter, 2014
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Oct. 16, 2014.
Original Filing: 300678668.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
21st Century Cures Initiative
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on July 18, 2014.
Original Filing: 300661737.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests. 21st Century Cures Initiative
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on April 7, 2014.
Original Filing: 300632983.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Jan. 8, 2014.
Original Filing: 300612002.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on Oct. 15, 2013.
Original Filing: 300593720.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on July 16, 2013.
Original Filing: 300572602.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Disease Research/Clinical Labs
1st Quarter, 2013
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $30,000. The report was filed on April 15, 2013.
Original Filing: 300550118.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Disease Research/Clinical Labs
4th Quarter, 2012
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on Jan. 15, 2013.
Original Filing: 300529486.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Disease Research/Clinical Labs
3rd Quarter, 2012
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $10,000. The report was filed on Oct. 19, 2012.
Original Filing: 300513429.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Disease Research/Clinical Labs
2nd Quarter, 2012
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $15,000. The report was filed on July 19, 2012.
Original Filing: 300492936.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Disease Research/Clinical Labs
1st Quarter, 2012
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $15,000. The report was filed on Jan. 10, 2012.
Original Filing: 300463221.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests
HR 3207.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $15,000. The report was filed on Jan. 10, 2012.
Original Filing: 300435746.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests
HR 3207.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $15,000. The report was filed on Oct. 19, 2011.
Original Filing: 300420164.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
HR 3207
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests
HR 3207.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $15,000. The report was filed on July 5, 2011.
Original Filing: 300386134.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
Goldbug Strategies LLC filed a lobbying registration on Oct. 18, 2012 to represent Coalition for 21st Century Medicine, effective Jan. 1, 2011.
Original Filing: 300513523.xml
Issue(s) they said they’d lobby about: FDA Regulation of laboratory developed tests; Medicare reimbursement of FDA regulated tests .
1st Quarter, 2011
In Q1, Goldbug Strategies LLC lobbied for Coalition for 21st Century Medicine , earning $40,000. The report was filed on April 14, 2011.
Original Filing: 300363937.xml
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
Goldbug Strategies LLC filed a lobbying registration on Feb. 8, 2011 to represent Coalition for 21st Century Medicine, effective Jan. 1, 2011.
Original Filing: 300357688.xml
Issue(s) they said they’d lobby about: FDA Regulation of laboratory developed tests; Medicare reimbursement of FDA regulated tests .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...